Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Computing & Software • Communications
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITY OF SOUTH AUSTRALIA currently manages 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. The distribution of 6 pending office actions across 6 distinct examiners and 6 distinct art units indicates a highly diverse set of biological or pharmaceutical inventions, each being reviewed by a different specialist group at the USPTO.
The busiest examiner, ARNOLD, ERNST V, holds 1 pending office action. With 6 distinct examiners each handling one of the 6 pending office actions, the workload is not concentrated. Practitioners must navigate 6 distinct art units, which likely means dealing with 6 different sets of examination priorities and timelines within the Biotechnology & Pharmaceuticals field. This lack of overlap suggests that the university's patent strategy involves a wide array of distinct technological sub-sectors, each requiring a unique approach to overcome specific examiner rejections.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARNOLD, ERNST V | 1 | 48.2% | +12.8% |
| KLIMOWICZ, WILLIAM JOSEPH | 1 | 80.8% | +18.2% |
| CABRAL, ROBERT S | 1 | 62.8% | +32.3% |
| VILLANUEVA, MARKUS ANTHONY | 1 | 60.0% | +30.7% |
| HERON, VELVET ELIZABETH | 1 | 52.4% | +43.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | — |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | — |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | — |
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | — |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | — |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | — |
| 17774078 | Pumpless Microfluidic Devices and Uses Thereof | HERON, VELVET ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 2688 | 1 |
| 1618 | 1 |
| 2151 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | 1613 | §102§103§112 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | 2688 | §103 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | 1618 | §102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | 2151 | §103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 17774078 | Pumpless Microfluidic Devices and Uses Thereof | HERON, VELVET ELIZABETH | 1798 | §103 | Non-Final OA | — | Pending | May 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITY OF SOUTH AUSTRALIA has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Ernst V Arnold has the most, with 1 of UNIVERSITY OF SOUTH AUSTRALIA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
